306. Eosinophilic sinusitis
[
1 clinical trial,
3 drugs（DrugBank:
3 drugs),
2 target genes / 8 target pathways ]
Searched query = "Eosinophilic sinusitis"
The queries were searched in Public_title, Scientific_title, and Condition of the data. Export date: 11/21/2019. Trials are sorted by Date_enrolment from most recent to oldest in the table.
| No. | TrialID | Date_ enrollement | Last_Refreshed_ on | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JPRN-UMIN000021822 | 2016/05/10 | 2 April 2019 | Study of the effect of the exhale through the nose method by Inhaled corticosteroid and Long Acting Beta2 Agonist (ICS / LABA) combination drug in patients with asthma merger sinusitis | Asthma Sinusitis Eosinophilic sinusitis | exhale through the nose method Fluticasone propionate / formoterol fumarate combination(:FFC) drug Inhaled by exhale through the nose method twice a day 2 times per once. Between three months. Inhalation Fluticasone propionate / formoterol fumarate combination(:FFC) drug Inhaled twice a day 2 times per once. Between three months. | Department of Otorhinolaryngology Showa University Koto Toyosu Hospital | Not Recruiting | 20years-old | 65years-old | Male and Female | 12 | Not applicable | Japan |